Teva Pharmaceutical Industries Ltd.
UkraineAll drugs from this manufacturer
-
The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: castration-resistant prostate cancer (with a mild course after androgen therapy or upon progression after docetaxel chemotherapy), as well as newly diagnosed high-risk hormone-sensitive prostate cancer in combination with androgen deprivation therapy.
Dosage form: tablets, film-coated
Active substance Dosage abiraterone 250 mg ATC: L02BX03
-
The drug is used for the treatment of advanced prostate cancer in combination with LHRH analogues or surgical castration.
Dosage form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg ATC: L02BB03
-
The drug is prescribed for the treatment of patients with locally advanced prostate cancer (as monotherapy or as an adjunct to surgery or radiotherapy) in cases of high risk of disease progression. It is also used for the treatment of locally advanced non-metastatic prostate cancer if surgery or castration is impossible or unacceptable.
Dosage form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg ATC: L02BB03
-
The drug is intended for the treatment of adult patients with relapsing-remitting multiple sclerosis.
Dosage form: capsules, hard gastro-resistant
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
The drug is intended for the treatment of adult patients with relapsing-remitting multiple sclerosis.
Dosage form: capsules, hard gastro-resistant
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The drug is prescribed for the treatment of type 2 diabetes mellitus in adults if blood sugar control cannot be achieved through diet, physical exercise, and weight reduction alone.
Dosage form: tablets
Active substance Dosage glimepiride 2 mg ATC: A10BB12
-
The drug is prescribed for adults with type 2 diabetes mellitus if blood sugar levels cannot be maintained by diet, physical exercise, and weight loss alone.
Dosage form: tablets
Active substance Dosage glimepiride 3 mg ATC: A10BB12
-
The drug is prescribed for adults with type 2 diabetes mellitus if blood sugar levels cannot be maintained by diet, physical exercise, and weight loss alone.
Dosage form: tablets
Active substance Dosage glimepiride 4 mg ATC: A10BB12
-
The drug is used to treat adults with unresectable or metastatic gastrointestinal stromal tumors (GIST), progressive or metastatic renal cell carcinoma (mRCC), as well as progressive unresectable or metastatic pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
-
The drug is prescribed to adults for the treatment of unresectable or metastatic gastrointestinal stromal tumors (GIST), progressive or metastatic renal cell carcinoma (mRCC), as well as progressive unresectable or metastatic pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
-
The drug is used to treat adults with unresectable or metastatic gastrointestinal stromal tumors (GIST), progressive renal cell carcinoma (RCC), and progressive pancreatic neuroendocrine tumors (pNET).
Dosage form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01